Serum amysoid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome

Glenner, 1983, Banbury Report 15, Biological aspects of Alzheimer's disease, 137

Shirahama, 1982, Senile cerebral amyloid: prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle and in the microangiopathic lesion, Am J Pathol, 107, 41

Ishii, 1975, Identification of components of immunoglobulins in senile plaques by means of fluroescent antibody technique, Acta Neuropathol (Berl), 32, 157, 10.1007/BF00689569

Powers, 1981, An immunoperoxidase study of senile cerebral amyloidosis with pathogenetic considerations, J Neurapathol Exp Neurol, 40, 592, 10.1097/00005072-198111000-00002

Torack, 1981, Cytochemistry of brain amyloid in adult dementia, Acta Neuropathol (Berl), 53, 189, 10.1007/BF00688021

Glenner, 1984, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem Biophys Res Commun, 120, 885, 10.1016/S0006-291X(84)80190-4

Masters, 1985, Amyloid plaque core protein in Alzheimer's disease and Down syndrome, Proc Natl Acad Sci (USA), 82, 4245, 10.1073/pnas.82.12.4245

Prusiner, 1984, Some speculations about prions, amyloid, and Alzheimer's disease, N Engl J Med, 310, 661, 10.1056/NEJM198403083101021

Kalter, 1975, Alzheimer's disease: Evaluation of immunologic indices, N Y State J Med, 81, 222

Cohen, 1980, Serum immunoglobulins and cognitive status in the elderly: a population study, Br J Psychiat, 136, 33, 10.1192/bjp.136.1.33

Williams, 1980, Demonstration of CSF gammaglobulin banding in presenile dementia, Neurol (N Y), 30, 882, 10.1212/WNL.30.8.882

Eikelenboom, 1984, An immunohistochemical study on cerebral vascular and senile plaque amyloid in Alzheimer's dementia, Virchows Arch (Cell Pathol), 47, 17, 10.1007/BF02890185

Glenner, 1980, Amyloid deposits and amyloidosis. The b-fibrilloses, N Eng J Med, 302, 1282

Maury, 1984, A review of reactive (secondary) amyloidosis and its pathogenesis, Rheumatol Int, 5, 1, 10.1007/BF00541358

Gorevis, 1976, Amyloidrelated serum component (SAA) -studies in acute infections, medullary thyroid carcinoma and post surgery. Behavior as an acute-phase reactant, Clin Immunol Immunopathpol, 6, 89

Benson, 1979, Serum amyloid A protein in amyloidosis, rheumatoid and neoplastic diseases, Artthritis Rheum, 22, 36, 10.1002/art.1780220106

Rosenthal, 1979, Serum amyloid A to monitor cancer dissemination, Ann Int Med, 91, 383, 10.7326/0003-4819-91-3-383

Maury, 1983, Serum amyloid A protein: a sensitive indicator of renal allograft rejection in humans, Transplantation, 36, 501, 10.1097/00007890-198311000-00006

Teppo, 1982, Characteristics of the amyloid-A-fibril degrading activity of human serum, Scand J Immunol, 16, 309, 10.1111/j.1365-3083.1982.tb00728.x

Maury, 1984, Serum esterase activity in reactive systemic amyloidosis and its relation to amyloid A degrading activity, J Lab Clin Med, 104, 761

Maury, 1982, Mechanism of reduced amyloid-A-degrading activity in serum of patients with secondary amyloidosis, Lancet, II, 234

Sulkava, 1982, Alzheimer's disease and senile dementia of Alzheimer type. A comparative study, Acta Neurol Scand, 65, 636, 10.1111/j.1600-0404.1982.tb03117.x

Ehnholm, 1985, Human highdensity lipoprotein associated amyloid A protein. Structural characteristics, relation to apoA-I and A-II concentrations, and plasma clearance kinetics in the rat, Scand J Rheumatol, 14, 201, 10.3109/03009748509165505

Rosenthal, 1975, Variation with age and disease of an amyloid A protein-related serum component, J Clin Invest, 55, 746, 10.1172/JCI107985

Iqnaczak, 1977, Immunochemical studies on the nature of the serum component (SAA) related to secondary amyloidosis, J Lab Clin Med, 89, 1092

Burgio, 1975, Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages, Eur J Immunol, 5, 600, 10.1002/eji.1830050904

Lott, 1982, Alzheimer's disease, Down's syndrome, and aging, 396, 15

Selinger, 1980, Monokine-induced synthesis of serum amyloid A protein by hepatocytes, Nature, 285, 498, 10.1038/285498a0

Sipe, 1982, The role of interleukin I in acute phase serum amyloid A (SAA) and serum amyloid P (SAP) biosynthesis, Ann N Y Acad, 389, 137, 10.1111/j.1749-6632.1982.tb22132.x

McAdam, 1982, The biology of SAA: identification of the inducer, in vitro synthesis, and heterogeneity demonstrated with monoclonal antibodies, Ann N Y Acad Sci, 386, 126, 10.1111/j.1749-6632.1982.tb22131.x

Clowes, 1983, Muscle proteolysis induced by a circulating peptide in septic and traumatized patients, N Engl J Med, 308, 545, 10.1056/NEJM198303103081001

Baracos, 1983, Stimulation of muscle protein degradation and prostagalndin E2 release by leucocyte pyrogen: a mechanism for the increased degradation of muscle proteins during fever, N Engl J Med, 308, 553, 10.1056/NEJM198303103081002

Maury, 1984, Control of the acute phase serum amuloid A response. Comparison of total replacement of hip and knee, Eur J Clin Invest, 14, 323, 10.1111/j.1365-2362.1984.tb01190.x

Falck, 1983, Persistently high serum amuloid A protein and C-reactive protein levels correlate with rapid progression of secondary amyloidosis, Br J Med, 286, 1391, 10.1136/bmj.286.6375.1391